Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant human papillomavirus type 18 vaccine

Recombinant human papillomavirus type 18 vaccine

US Patent 5820870 · Granted Oct 13, 1998

Estimated economic value: $104,094,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Neisseria meningitidis compositions and methods thereof2025
Immunogenic compositions for use in pneumococcal vaccines2025
Compositions and methods relating to a mutant Clostridium difficile toxin2024
Immunogenic compositions comprising conjugated capsular saccharide antigens and 2024
Neisseria meningitidis compositions and methods thereof2023
Neisseria meningitidis compositions and methods thereof2023
Compositions relating to a mutant clostridium difficile toxin and methods thereo2022
Neisseria meningitidis composition and methods thereof2022
Immunogenic compositions for use in pneumococcal vaccines2022
Compositions and methods relating to a mutant Clostridium difficile toxin2021
Compositions relating to a mutant Clostridium difficile toxin and methods thereo2021
Compositions relating to a mutant Clostridium difficile toxin and methods thereo2021